Showing results (201-210 of 212) with videos related to
Sort By:
Pageof 22
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.BMC Medical Research Methodology|January 31, 2022
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international networkRoss D Williams, Aniek F Markus, Cynthia Yang, et al.Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudyRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network studyEdward Burn, Seng Chan You, Anthony Sena, et al.The Lancet. Rheumatology|September 1, 2020
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.Research Square|March 10, 2021
Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDISDaniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles, et al.Pageof 22